RA Capital Management, L.P. 13D and 13G filings for Mineralys Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-17 7:58 pm Purchase |
2025-03-13 | 13D | Mineralys Therapeutics, Inc. MLYS |
RA Capital Management, L.P. | 6,287,597 9.900% |
1,338,290 (+27.04%) |
Filing |
| 2024-02-12 4:49 pm Purchase |
2024-02-12 | 13D | Mineralys Therapeutics, Inc. MLYS |
RA Capital Management, L.P. | 4,949,307 9.990% |
1,768,387 (+55.59%) |
Filing |
| 2023-02-24 4:30 pm Purchase |
2023-02-14 | 13D | Mineralys Therapeutics, Inc. MLYS |
RA Capital Management, L.P. | 3,180,920 7.800% |
3,180,920 (New Position) |
Filing |